PLK1 and hepatocellular carcinoma: Finally, we found that SIS3, a specific inhibitor of Smad3, enhanced the effects of PLK1 inhibitor on the growth, apoptosis, and cell cycle in HCC cells carrying TERT mutation in low concentration.